Empowering Oncology Decisions

DiagnoCure Oncology Laboratories (DOL) is a life sciences company offering high-value cancer testing laboratory services that increase clinician and patient confidence in making critical treatment decisions. More (PDF)

DiagnoCure now offers Previstage™ GCC, the first molecular test for colorectal cancer staging. The test detects occult metastases in lymph nodes removed during the colorectal cancer surgery, identifying patients who may be at increased risk of developing recurrent disease and who could most benefit from adjuvant chemotherapy. With a detection capacity that is close to 100,000 x more sensitive than microscopic staging methods, Previstage™ GCC provides clinicians with significantly more accurate information for staging a patient with colorectal cancer that will increase their confidence in making critical treatment decisions.

DiagnoCure Oncology Laboratories is a subsidiary of DiagnoCure Inc. To obtain more information, including financials and investment opportunity, visit DiagnoCure.com.